Skip to main content
. 2023 Sep 21;11(9):e007110. doi: 10.1136/jitc-2023-007110

Figure 7.

Figure 7

PMN-MDSCs from tumor bearing mice enable A1207 tumor growth. Ly6G+ cells were harvested from spleens of C57BL/6 mice without tumors or bearing A1206 tumors on day 0, 5, 11 and 16. 0.5 million A1207+1.5 million Ly6G+ cells were transplanted to the flanks of recipient C57BL/6 mice on day 0. Initiated tumors were transplanted with another 1.5 million Ly6G+ cells on days 5, 11 and 16. Rate of complete A1207 tumor clearance was monitored over time. *p<0.05 determined by log-rank test. PMN-MDSCs; polymorphonuclear myeloid-derived suppressor cells; WT, wild type.